AstraZeneca: "The risk of thrombosis is a little higher in young subjects", explains Bernard Bégaud

2021-04-20T05:12:36.004Z

Sébastien Krebs receives Bernard Bégaud, pharmacologist at the University of Bordeaux. He talks with him about the risks of the AstraZeneca vaccine. According to the specialist, the benefit / risk calculation is very favorable for the vaccine, in particular in the oldest populations. & Nbsp;